Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Heart Journal

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHM194PMID 17575270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).

  2006cited by this paper
• ACC/AHA/SCAI Practice Guidelines, February 21, 2006

  2006cited by this paper
• Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

  2006cited by this paper
• Predictors of in-hospital and 30-day complications of peripheral vascular interventions using bivalirudin as the primary anticoagulant: results from the APPROVE Registry.

  2005cited by this paper
• The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.

  2005cited by this paper
• The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial.

  2005cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.

  2005cited by this paper
• Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).

  2005cited by this paper
• Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.

  2005cited by this paper
• Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

  2005cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• Bleeding complications in patients with anemia and acute myocardial infarction.

  2005cited by this paper
• Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

  2004cited by this paper
• Impact of female sex on outcome after percutaneous coronary intervention.

  2004cited by this paper
• The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes

  2004cited by this paper
• Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients.

  2004cited by this paper
• Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

  2004cited by this paper
• Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

  2004cited by this paper
• Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.

  2004cited by this paper
• The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with NonST-Segment Elevation Acute Coronary Syndromes

  2004cited by this paper
• Relationship Between Activated Clotting Time and Ischemic or Hemorrhagic Complications: Analysis of 4 Recent Randomized Clinical Trials of Percutaneous Coronary Intervention

  2004cited by this paper
• Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy.

  2003cited by this paper
• Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial.

  2003cited by this paper
• Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention.

  2003cited by this paper
• Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials.

  2003cited by this paper
• Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.

  2003cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Survival After Coronary Revascularization in the Elderly

  2002cited by this paper
• Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.

  2002cited by this paper
• Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

  2002cited by this paper
• AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.

  2001cited by this paper
• The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry.

  2001cited by this paper
• The use of bivalirudin in patients with renal impairment.

  2000cited by this paper
• Population based study of social and productive activities as predictors of survival among elderly Americans

  1999cited by this paper
• Randomised placebo-controlled and balloon-angioplasty- controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Abciximab and alveolar hemorrhage.

  1998cited by this paper
• Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.

  1997cited by this paper
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.

  1997cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators.

  1994cited by this paper
• Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

  1994cited by this paper
• CARDIOVASCULAR DISEASE IN THE ELDERLY

  1986cited by this paper

• Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

  2025cites this paper
• Preoperative Factors Associated With In-Hospital Major Bleeding After Percutaneous Coronary Intervention: A Systematic Review.

  2025cites this paper
• The Negative Influence and Adverse Outcome of Red Blood Cell Transfusion in Contemporary Percutaneous Coronary Interventions

  2025cites this paper
• Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

  2025cites this paper
• DO TEACHING HOSPITALS HAVE COMPARABLE OUTCOMES TO NON-TEACHING HOSPITALS FOR PERCUTANEOUS CORONARY INTERVENTIONS?

  2024cites this paper
• Impact of anemia on major bleeding in patients taking oral anticoagulants for nonvalvular atrial fibrillation

  2023cites this paper
• Tailoring Antithrombotic Regimens for Percutaneous Coronary Intervention Patients with High Bleeding and Ischemic Risk (TAILOR-BIRISK): Individualized Management and Genotype-Guided De-escalation

  2023cites this paper
• The Management and Antithrombotic Strategies of Patients with Coronary Artery Disease and High Bleeding Risk

  2023cites this paper
• Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship

  2023cites this paper
• Sex Differences in Baseline Characteristics Do Not Predict Early Outcomes after Percutaneous Coronary Intervention: Results from the Australian GenesisCare Cardiovascular Outcomes Registry (GCOR)

  2022cites this paper
• Performance of stent thrombosis and bleeding risk scores in out-of-hospital cardiac arrest due to acute coronary syndromes.

  2022cites this paper
• Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry

  2022cites this paper
• Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack

  2021cites this paper
• Analysis of Immune Associated Co-Expression Networks Reveals Immune-Related Long Non-Coding RNAs during MI in the Presence and Absence of HDC

  2021cites this paper
• SCAI expert consensus update on best practices in the cardiac catheterization laboratory

  2021cites this paper
• Acute Anemia and Myocardial Infarction

  2021cites this paper
• Evaluation of Bleeding Risk Prior to Invasive Procedures

  2021cites this paper
• The safety and efficacy of haemostasis with a catechol-conjugated, chitosan-based haemostatic dressing versus a chitosan-based haemostatic dressing after transfemoral approach for transcatheter arterial chemoembolization: a randomized controlled trial

  2021cites this paper
• Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis

  2021cites this paper
• Derivation and validation of a combined in-hospital mortality and bleeding risk model in acute myocardial infarction

  2021cites this paper
• Development and external validation of a diagnostic model for in-hospital bleedingin patients with acute ST elevation myocardial infarction

  2020cites this paper
• Managing retroperitoneal hematoma: Associated complexities and its challenges.

  2020cites this paper
• Upper gastrointestinal bleeding in Japanese patients with ischemic heart disease receiving vonoprazan or a proton pump inhibitor with multiple antithrombotic agents: A nationwide database study.

  2020cites this paper
• Development and External Validation of a Diagnostic Model for in-Hospital Mortality in Patient with Acute ST Elevation Myocardial Infarction

  2020cites this paper
• Development and external validation of a diagnostic model for in-hospital bleeding in patients with acute ST elevation myocardial infarction

  2020cites this paper
• Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina

  2020cites this paper
• Modern Management of ST-Segment Elevation Myocardial Infarction.

  2020cites this paper
• A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC‐ACS study

  2019cites this paper
• Impact of decreased ankle-brachial index on 30-day bleeding complications and long-term mortality in patients with acute coronary syndrome after percutaneous coronary intervention.

  2019cites this paper
• Development and Evaluation of Novel Electronic Medical Record Tools For Avoiding Bleeding After Percutaneous Coronary Intervention

  2019cites this paper
• Optimal Antithrombotic Therapy for Patients with STEMI Undergoing PCI at High Risk of Bleeding

  2019cites this paper
• Coronary Shear Stress after Implantation of Bioresorbable Scaffolds – a Modern Interdisciplinary Concept at the Border between Interventional Cardiology and Cardiac Imaging

  2019cites this paper
• Klinische Studien/Klinische Praxis: Einheitliche Blutungsdefinition zur besseren Vergleichbarkeit des Blutungsrisikos im akuten Koronarsyndrom unter Adenosindiphosphat-Rezeptor- (P2Y12-) Inhibition

  2019cites this paper
• ETUDE DES FACTEURS PREDICTIFS DE L’ATTEINTE DE LA MICROCIRCULATION CORONAIRE INDUITE PAR ANGIOPLASTIE ELECTIVE, MESUREE PAR L’INDEX OF MICROCIRCULATORY RESISTANCE (IMR), CHEZ DES PATIENTS SOUFFRANT D’ANGOR STABLE.

  2019cites this paper
• Asociación entre las escalas de riesgo isquémico y hemorrágico y el uso de los nuevos inhibidores del P2Y 12 en pacientes con síndrome coronario agudo

  2018cites this paper
• The Design and Clinimetrics of Post-Operative Bleeding Prediction Tool (POPBT) in Intensive Care Unit

  2018cites this paper
• Prozedurbedingte Blutungen bei elektiven perkutanen Koronarinterventionen

  2018influential citation
• CRUSADE: Is it still a good score to predict bleeding in acute coronary syndrome?

  2018cites this paper
• Risks and Complications of Coronary Angiography and Other Percutaneous Intervention: A Comprehensive Review with Data of Single High Volume Center

  2018cites this paper
• Clinical outcomes of patients with acute coronary syndrome and moderate or severe chronic anaemia undergoing coronary angiography or intervention

  2018cites this paper
• CRUSADE: Is it still a good score to predict bleeding in acute coronary syndrome?

  2018cites this paper
• Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.

  2018cites this paper
• The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.

  2018cites this paper
• Association of Anemia With Outcomes Among ST-Segment–Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention

  2018cites this paper
• A CROSS-SECTIONAL RESEARCH ON PCI (PERCUTANEOUS CORONARY INTERVENTION, BLEEDING SITE & ASSOCIATED RISK FACTORS IN CONTEXT TO MAJOR & MINOR BLEEDING & BLEEDING DEFINITIONS

  2018cites this paper
• Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention

  2017cites this paper
• Bivalirudin for patients with STEMI at high risk of bleeding undergoing PPCI

  2017cites this paper
• Bleeding associated with the management of acute coronary syndromes

  2017cites this paper
• Incidence and predictors of bleeding complications after percutaneous coronary intervention.

  2017cites this paper
• Gender‐related differences on short‐ and long‐term outcomes of patients undergoing transcatheter aortic valve implantation

  2017cites this paper
• Coronary artery disease: Risk stratification and patient selection for more aggressive secondary prevention

  2017cites this paper
• Update on primary PCI for patients with STEMI.

  2017cites this paper
• Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1)

  2017cites this paper
• Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.

  2017cites this paper
• One‐Year Survival is Not Affected by Gastrointestinal Bleeding After Percutaneous Coronary Interventions

  2017cites this paper
• Contemporary risk model for inhospital major bleeding for patients with acute myocardial infarction: The acute coronary treatment and intervention outcomes network (ACTION) registry®–Get With The Guidelines (GWTG)®

  2017cites this paper
• Drug-Eluting Stents Are Effective in Women: Only Part of the Story?

  2016cites this paper
• Dengue score: a proposed diagnostic predictor for pleural effusion and/or ascites in adults with dengue infection

  2016cites this paper
• One‐year clinical outcomes after sirolimus‐eluting coronary stent implantation in diabetics enrolled in the worldwide e‐SELECT registry

  2016cites this paper
• Antipsychotic Use in Hospitalized Adults: Rates, Indications, and Predictors

  2016cites this paper
• Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel.

  2016cites this paper
• Prevencion de complicaciones hemorragicas en el sindrome coronario agudo

  2016cites this paper
• Characteristics of Coronary Lesions in Small Vessel Disease Treated with Elective Stenting in Patients with Type 2 Diabetes Mellitus

  2016cites this paper
• SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Association of interventional cardiology–Association ca

  2016cites this paper
• Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.

  2016cites this paper
• Drug-Eluting Stents Are Effective in Women

  2016cites this paper
• Prediction of 1‐year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient‐level pooled analysis from three randomized trials

  2016cites this paper
• Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials.

  2016cites this paper
• Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease.

  2016cites this paper
• Development and Validation of a Preprocedural Risk Score to Predict Access Site Complications After Peripheral Vascular Interventions Based on the Vascular Quality Initiative Database

  2016cites this paper
• Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.

  2016cites this paper
• Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association

  2016cites this paper
• rends in Vascular Complications After Diagnostic ardiac Catheterization and Percutaneous oronary Intervention Via the Femoral Artery , 998 to 2007

  2016cites this paper
• The association between the extent of coronary artery disease and major bleeding events after percutaneous coronary intervention: from the ACUITY trial.

  2015cites this paper
• Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?

  2015cites this paper
• Unexpected Discontinuation of Dual Antiplatelet Therapy within 14 Days after Percutaneous Coronary Intervention: A Single-center Case Series.

  2015cites this paper
• Association of bleeding, mortality and sex in acute coronary syndromes: the missing triangle

  2015cites this paper
• Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.

  2015cites this paper
• Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients

  2015cites this paper
• Validity of a PCI Bleeding Risk Score in patient subsets stratified for body mass index

  2015cites this paper
• Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach?

  2015cites this paper
• Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score

  2015cites this paper
• 急性心筋梗塞による冠動脈ステント留置術後, 心肺蘇生術による肝・胆嚢損傷から出血性ショックとなった1例

  2015cites this paper
• Predictive ability of bleeding risk scores in the routine clinical practice

  2015cites this paper
• Femoral Access PCI in a Default Radial Center Identifies High-Risk Patients With Poor Outcomes.

  2015cites this paper
• Transradial Primary Percutaneous Coronary Intervention.

  2015cites this paper
• Predicting and preventing vascular complications following percutaneous coronary intervention in women

  2015cites this paper
• Impact of Early Invasive Approach on Outcomes of Patients With Acute Coronary Syndrome and Baseline Anemia: Analysis From the ACSIS Registry.

  2015cites this paper
• Comparison of Intravenous plus Oral Pantoprazole Therapy and Oral Pantoprazole Alone for Preventing Gastrointestinal Bleeding in Acute Coronary Syndrome Patients with High Bleeding Risk.

  2015cites this paper
• Prognosis of Patients with Acute Coronary Syndromes and Bleeding—The Importance of Routine Use of a Bleeding Risk Score

  2015cites this paper
• Beneficial Effects of a Point‐of‐Care Bleeding Risk Calculator on Anticoagulant Selection in the Coronary Catheterization Laboratory

  2015cites this paper
• Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention.

  2015cites this paper
• Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention Učestalost, prediktori i prognozni značaj krvarenja kao komplikacije primarne perkutane koronarne intervencije

  2015cites this paper
• Bleeding complications in patients undergoing percutaneous coronary interventions: current status and perspective.

  2014cites this paper
• Acesso Radial vs. Acesso Femoral em Pacientes com Idade Avançada Submetidos à Intervenção Coronária Percutânea

  2014cites this paper
• Stents Bioabsorvíveis uma nova era no tratamento da doença arterial coronária

  2014cites this paper
• Use of the CRUSADE bleeding risk score in the prediction of major bleeding for patients with acute coronary syndrome receiving enoxaparin in Thailand.

  2014cites this paper
• Prescribing Proton Pump Inhibitor and Clopidogrel Together

  2014cites this paper
• Vascular complications following cardiac catheterization at Jordan University Hospital

  2014cites this paper
• An Independent and External Validation of the ACC NCDR Bleeding Risk Score among a National Multi-Site Community Hospital Registry of Cardiac Interventions

  2014cites this paper